KEIO RESEARCHERS INFORMATION SYSTEM

Profile 【 Display / hide 】

Profile 【 Display / hide 】

• Miho Iida, MD, PhD, is an obstetrician–gynecologist, occupational health physician, and public health researcher based in Japan. Her research focuses on women’s health across the life course, including menstrual health, reproductive health, menopause, and aging, by integrating biological data with social and workplace factors.
  She is the Principal Investigator of the aging substudy and the women’s health substudy within the Tsuruoka Metabolomics Cohort Study, a long-running population-based cohort established in 2012 in Japan. She is also involved in several cohort studies focusing on women’s health among working populations.

Other Affiliation 【 Display / hide 】

Other Affiliation 【 Display / hide 】

• School of Medicine, Obstetrics and Gynecology

Career 【 Display / hide 】

Career 【 Display / hide 】

• 2008.04

  -

  2010.03

  Kameda Medical Center, Residency

• 2010.04

  -

  2014.03

  Keio University Hospital, Obstetrics and Gynecology, Residency/Fellowship

• 2011.04

  -

  2012.03

  Saiseikai Utsunomiya Hospital, Obstetrics and Gynecology, Residency/Fellowship

• 2012.04

  -

  2013.03

  Kawasaki Municipal Hospital, Obstetrics and Gynecology, Residency/Fellowship

• 2017.10

  -

  2018.03

  Keio University Hospital, Obstetrics and Gynecology, Assistant Professor

display all >>

Academic Background 【 Display / hide 】

Academic Background 【 Display / hide 】

• 2002.04

  -

  2008.03

  Keio University, School of Medicine, 医学科

  University, Graduated, Master's course

• 2014.04

  -

  2017.09

  Keio University, Graduate School of Medicine, PhD Course

  Graduate School, Completed, Doctoral course

Academic Degrees 【 Display / hide 】

Academic Degrees 【 Display / hide 】

• PhD (medicine), Keio University School of Medicine, Coursework, 2017.09

  Profiling of plasma metabolites in postmenopausal women with metabolic syndrome

Licenses and Qualifications 【 Display / hide 】

Licenses and Qualifications 【 Display / hide 】

• Board Certified Supervisory Physician for Public Health and Social Medicine, 2022.04

• Medical license, 2008.04

• Board Certified Physician for Obstetrics and Gynecology, 2013.10

• Board Certified Physician for Anti-Aging Medicine, 2017.01

• Board Certified Physician for Public Health and Social Medicine , 2017.04

display all >>

Research Areas 【 Display / hide 】

Research Areas 【 Display / hide 】

• Life Science / Obstetrics and gynecology

• Life Science / Hygiene and public health (laboratory)

• Life Science / Hygiene and public health (non-laboratory)

• Life Science / Medical management and medical sociology

Research Keywords 【 Display / hide 】

Research Keywords 【 Display / hide 】

• Metabolomics

• Preventive Medicine

• Public Health

• Women's Health

• Occupational Health

Books 【 Display / hide 】

Books 【 Display / hide 】

• 更年期以降の健康課題×フェムテック

  飯田　美穂, （株）ロギカ書房, 2022.10

  Contact page： 205-214

• Endometrial Cancer: Current Epidemiology, Detection and Management

  Banno K, IIDA Miho, Farghaly SA, Umene K, Kisu I, Aoki D, Nova Science Publishers, Inc., 2014,  Page： 17

  Scope: Novel Therapeutic Agents for Treatment of Endometrial Cancer,  Contact page： 321-337

  　View Summary

  Endometrial cancer is a female genital cancer that occurs frequently in Europe and the United States. Conventional therapy for endometrial cancer does not permit fertility preservation or have effects on advanced and recurrent cancers, and new pharmacotherapies are needed. The fourth-generation progestin, dienogest, blocks excessive estrogenic activity and inhibits endometrial overgrowth. Metformin is an antidiabetic drug that may have an effect on endometrial cancer through targeting of the mammalian target of rapamycin (mTOR) pathway. mTOR inhibitors block cancer growth by arresting the cell cycle in G1 phase and clinical trials of new generation drugs with multiple sites of action in the mTOR pathway are underway. To inhibit down regulation of tumor suppressor genes by DNA hypermethylation and histone deacetylation, drugs targeting DNA methyltransferase (DNMT), microRNA (miRNA) and histone deacetylase (HDAC) are under development. AEZS-108 targeted to LHRH receptors on tumors is an effective compound for chemotherapy of endometrial cancer. In addition, targeting STAT3 or Wnt/β-catenin pathway by specific inhibitor in tumor cells and immunosuppressive cells, or along with other immunotherapy, might restore the immunocompetence of endometrial cancer patients. The oncogenic mechanisms underlying endometrial cancer, and regulatory factors based on the characteristics of endometrial cancer cells are gradually emerging. These data are likely to lead to development of new effective therapy for this disease.

Papers 【 Display / hide 】

Papers 【 Display / hide 】

• Recognizing Female Reproductive Factors in Interpreting Changes in Disease Burden Among Populations

  Iida M.

  Journal of epidemiology 34 ( 8 ) 363 - 364 2024.08

  • Access to Document (DOI)

• Study Profile of the Tsuruoka Metabolomics Cohort Study (TMCS)

  Harada S., Iida M., Miyagawa N., Hirata A., Kuwabara K., Matsumoto M., Okamura T., Edagawa S., Kawada Y., Miyake A., Toki R., Akiyama M., Kawai A., Sugiyama D., Sato Y., Takemura R., Fukai K., Ishibashi Y., Kato S., Kurihara A., Sata M., Shibuki T., Takeuchi A., Kohsaka S., Sawano M., Shoji S., Izawa Y., Katsumata M., Oki K., Takahashi S., Takizawa T., Maruya H., Nishiwaki Y., Kawasaki R., Hirayama A., Ishikawa T., Saito R., Sato A., Soga T., Sugimoto M., Tomita M., Komaki S., Ohmomo H., Ono K., Otsuka-Yamasaki Y., Shimizu A., Sutoh Y., Hozawa A., Kinoshita K., Koshiba S., Kumada K., Ogishima S., Sakurai-Yageta M., Tamiya G., Takebayashi T.

  Journal of epidemiology 34 ( 8 ) 393 - 401 2024.08

  　View Summary

  The Tsuruoka Metabolomics Cohort Study (TMCS) is an ongoing population-based cohort study being conducted in the rural area of Yamagata Prefecture, Japan. This study aimed to enhance the precision prevention of multi-factorial, complex diseases, including non-communicable and aging-associated diseases, by improving risk stratification and prediction measures. At baseline, 11,002 participants aged 35-74 years were recruited in Tsuruoka City, Yamagata Prefecture, Japan, between 2012 and 2015, with an ongoing follow-up survey. Participants underwent various measurements, examinations, tests, and questionnaires on their health, lifestyle, and social factors. This study uses an integrative approach with deep molecular profiling to identify potential biomarkers linked to phenotypes that underpin disease pathophysiology and provide better mechanistic insights into social health determinants. The TMCS incorporates multi-omics data, including genetic and metabolomic analyses of 10,933 participants, and comprehensive data collection ranging from physical, psychological, behavioral, and social to biological data. The metabolome is used as a phenotypic probe because it is sensitive to changes in physiological and external conditions. The TMCS focuses on collecting outcomes for cardiovascular disease, cancer incidence and mortality, disability and functional decline due to aging and disease sequelae, and the variation in health status within the body represented by omics analysis that lies between exposure and disease. It contains several sub-studies on aging, heated tobacco products, and women's health. This study is notable for its robust design, high participation rate (89%), and long-term repeated surveys. Moreover, it contributes to precision prevention in Japan and East Asia as a well-established multi-omics platform.

  • Access to Document (DOI)

• Association of Nonalcoholic Fatty Liver Disease with Arterial Stiffness and its Metabolomic Profiling in Japanese Community-Dwellers

  Hirata A., Harada S., Iida M., Kurihara A., Fukai K., Kuwabara K., Kato S., Matsumoto M., Sata M., Miyagawa N., Toki R., Edagawa S., Sugiyama D., Sato A., Hirayama A., Sugimoto M., Soga T., Tomita M., Okamura T., Takebayashi T.

  Journal of atherosclerosis and thrombosis 31 ( 7 ) 1031 - 1047 2024.07

  　View Summary

  AIMS: Nonalcoholic fatty liver disease (NAFLD) is known to be associated with atherosclerosis. This study focused on upstream changes in the process by which NAFLD leads to atherosclerosis. The study aimed to confirm the association between NAFLD and the cardio-ankle vascular index (CAVI), an indicator of subclinical atherosclerosis, and explore metabolites involved in both by assessing 94 plasma polar metabolites. METHODS: A total of 928 Japanese community-dwellers (306 men and 622 women) were included in this study. The association between NAFLD and CAVI was examined using a multivariable regression model adjusted for confounders. Metabolites commonly associated with NAFLD and CAVI were investigated using linear mixed-effects models in which batch numbers of metabolite measurements were used as a random-effects variable, and false discovery rate-adjusted p-values were calculated. To determine the extent to which these metabolites mediated the association between NAFLD and CAVI, mediation analysis was conducted. RESULTS: NAFLD was positively associated with CAVI (coefficients [95% Confidence intervals (CI)]=0.23 [0.09-0.37]; p=0.001). A total of 10 metabolites were involved in NAFLD and CAVI, namely, branched-chain amino acids (BCAAs; valine, leucine, and isoleucine), aromatic amino acids (AAAs; tyrosine and tryptophan), alanine, proline, glutamic acid, glycerophosphorylcholine, and 4-methyl-2-oxopentanoate. Mediation analysis showed that BCAAs mediated more than 20% of the total effect in the association between NAFLD and CAVI. CONCLUSIONS: NAFLD was associated with a marker of atherosclerosis, and several metabolites related to insulin resistance, including BCAAs and AAAs, could be involved in the process by which NAFLD leads to atherosclerosis.

  • Access to Document (DOI)

• Reliability of Time-Series Plasma Metabolome Data over 6 Years in a Large-Scale Cohort Study

  Miyake A., Harada S., Sugiyama D., Matsumoto M., Hirata A., Miyagawa N., Toki R., Edagawa S., Kuwabara K., Okamura T., Sato A., Amano K., Hirayama A., Sugimoto M., Soga T., Tomita M., Arakawa K., Takebayashi T., Iida M.

  Metabolites 14 ( 1 )  2024.01

  　View Summary

  Studies examining long-term longitudinal metabolomic data and their reliability in large-scale populations are limited. Therefore, we aimed to evaluate the reliability of repeated measurements of plasma metabolites in a prospective cohort setting and to explore intra-individual concentration changes at three time points over a 6-year period. The study participants included 2999 individuals (1317 men and 1682 women) from the Tsuruoka Metabolomics Cohort Study, who participated in all three surveys—at baseline, 3 years, and 6 years. In each survey, 94 plasma metabolites were quantified for each individual and quality control (QC) sample. The coefficients of variation of QC, intraclass correlation coefficients, and change rates of QC were calculated for each metabolite, and their reliability was classified into three categories: excellent, fair to good, and poor. Seventy-six percent (71/94) of metabolites were classified as fair to good or better. Of the 39 metabolites grouped as excellent, 29 (74%) in men and 26 (67%) in women showed significant intra-individual changes over 6 years. Overall, our study demonstrated a high degree of reliability for repeated metabolome measurements. Many highly reliable metabolites showed significant changes over the 6-year period, suggesting that repeated longitudinal metabolome measurements are useful for epidemiological studies.

  • Access to Document (DOI)

• Scale development and validation of perimenopausal women disability index in the workplace

  Nomura K., Shimizu K., Taka F., Griffith-Quintyne M., Iida M.

  Environmental Health and Preventive Medicine 29 2024

  ISSN  1342078X

  　View Summary

  Background: Menopausal disorders include obscure symptomatology that greatly reduce work productivity among female workers. Quantifying the impact of menopause-related symptoms on work productivity is very difficult because no such guidelines exist to date. We aimed to develop a scale of overall health status for working women in the perimenopausal period. Methods: In September, 2021, we conducted an Internet web survey which included 3,645 female workers aged 45–56 years in perimenopausal period. We asked the participants to answer 76 items relevant to menopausal symptomatology, that were created for this study and performed exploratory and confirmatory factor analyses for the scale development. Cronbach’s alpha, receiver operating characteristic analysis, and logistic regression analysis were used to verify the developed scale. Results: Approximately 85% participants did not have menstruation or disrupted cycles. Explanatory factor analysis using the maximum likelihood method and Promax rotation identified 21 items with a four-factor structure: psychological symptoms (8 items, α = 0.96); physiological symptoms (6 items, alpha = 0.87); sleep difficulty (4 items, alpha = 0.92); human relationship (3 items, alpha = 0.92). Confirmatory factor analyses found excellent model fit for the four-factor model (RMSR = 0.079; TLI = 0.929; CFI = 0.938). Criterion and concurrent validity were confirmed with high correlation coefficients between each of the four factors, previously validated menopausal symptom questionnaire, and Copenhagen Burnout Inventory scales, respectively (all ps < 0.0001). The developed scale was able to predict absenteeism with 78% sensitivity, 58% specificity, and an AUC of 0.727 (95%CI: 0.696–0.757). Higher scores of each factor as well as total score of the scale were more likely to be associated with work absence experience due to menopause-related symptoms even after adjusting for Copenhagen Burnout Inventory subscales (all ps < 0.0001). Conclusion: We found that the developed scale has high validity and reliability and could be a significant indicator of absenteeism for working women in perimenopausal period.

  • Access to Document (DOI)

display all >>

Papers, etc., Registered in KOARA 【 Display / hide 】

Papers, etc., Registered in KOARA 【 Display / hide 】

• Integration of genomics and metabolomics for prevention of menopausal disorders

  Iida, Miho

  科学研究費補助金研究成果報告書 2022

• Profiling of steroid hormone for women's health and wellbeing : metabolomics cohort study

  Iida, Miho

  科学研究費補助金研究成果報告書 2022

• Metabolome-wide metabolic profiling and non-communicable disease prevention in a population-based cohort study

  Iida, Miho

  科学研究費補助金研究成果報告書 2018

• 閉経後女性におけるメタボリック症候群の血漿メタボローム・プロファイリング

  Iida, Miho

  (慶應義塾大学大学院医学研究科)  2017

• Investigation of obesity-related metabolic markers in plasma and urine using metabolome profiling

  Iida, Miho

  科学研究費補助金研究成果報告書 2017

Reviews, Commentaries, etc. 【 Display / hide 】

Reviews, Commentaries, etc. 【 Display / hide 】

• Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan

  Namba M., Kaneda Y., Iida M.

  Therapeutic Advances in Vaccines and Immunotherapy 11 2023.01

  ISSN  25151355

  • Access to Document (DOI)

• 更年期以降の健康課題とフェムテック

  飯田　美穂

  産婦人科の実際 (金原出版)  71 ( 13 ) 1553 - 1561 2022.12

  Article, review, commentary, editorial, etc. (scientific journal), Single Work, Lead author,  ISSN  05584728

• Serum modified high-density lipoprotein and risk of atherosclerotic cardiovascular disease in a Japanese community-based nested case-control study

  Sata M., Kakino A., Hirata A., Iida M., Usami Y., Harada S., Fujita Y., Kohsaka S., Izawa Y., Sawano M., Oki K., Sugiyama D., Takahashi S., Takebayashi T., Sawamura T., Okamura T.

  European Journal of Preventive Cardiology 29 ( 5 ) E193 - E195 2022.03

  ISSN  20474873

  • Access to Document (DOI)

• Importance of Sex Differences in Research on Cardiovascular Disease Prevention

  Iida M.

  Journal of Atherosclerosis and Thrombosis 29 ( 10 ) 1427 - 1429 2022

  ISSN  13403478

  • Access to Document (DOI)

• Erratum: Charged metabolite biomarkers of food intake assessed via plasma metabolomics in a population-based observational study in Japan (PLoS ONE (2021) 16:2 (e0246456) DOI: 10.1371/journal.pone.0246456)

  Shibutami E., Ishii R., Harada S., Kurihara A., Kuwabara K., Kato S., Iida M., Akiyama M., Sugiyama D., Hirayama A., Sato A., Amano K., Sugimoto M., Soga T., Tomita M., Takebayashi T.

  PLoS ONE 16 ( 4 April )  2021.04

  　View Summary

  In Table 2, the mean (10th-90th range)a of Rice for Male should be (250-680). Please see the correct Table 2 here. (Table Presented).

  • Access to Document (DOI)

display all >>

Presentations 【 Display / hide 】

Presentations 【 Display / hide 】

• A longitudinal study on metabolic profiling of menopause: a large-scale population-based cohort study in Japan

  Atsuko Miyake*1*2, Miho Iida*2, Toru Takebayashi*2, Kouji Banno*1, Wataru Yamagami*1, Mamoru Tanaka*1

  [Domestic presentation]  第76回 日本産科婦人科学会学術講演会 (横浜) , 

  2024.04

• 習慣的飲酒と尿メタボロームの関連：鶴岡メタボロームコホート研究

  原田 成, 飯田美穂, 宮川尚子, 平田あや, 松元美奈子,土岐了大, 枝川 峻, 岡村智教, 武林 亨

  [Domestic presentation]  第94回　日本衛生学会 (熊本) , 

  2024.03

• 日本の地域住民における喫煙習慣の有無別の血清総ビリルビンと脳・心血管疾患発症との関連

  平田あや1、原田成1、飯田美穂1、宮川尚子1、松元美奈子1、土岐了大1、枝川俊1、三宅温子1、桑原和代1、杉山大典1,2、岡村智教1、武林亨1

  [Domestic presentation]  第34回　日本疫学会学術総会 (滋賀県大津市・びわ湖大津プリンスホテル) , 

  2024.01

  -

  2024.02

  , 

  日本疫学会

• 日本人集団における血中アミノ酸濃度のゲノムワイド関連解析(GWAS)とそれを用いた疾患との関連研究

  土岐了大, 小島駿, 伏木蒼太郎, 原田成, 平田あや, 飯田美穂, 松元美奈子, 宮川尚子, 枝川竣, 三宅温子, 須藤洋一, 大桃秀樹, 山崎弥生, 岡村智教, 清水厚志, 武林亨

  [Domestic presentation]  第34回　日本疫学会学術総会 (滋賀県大津市・びわ湖大津プリンスホテル) , 

  2024.01

  -

  2024.02

  , 

  日本疫学会

• Association of BMI at age 18 and subsequent infertility: Japan Nurses' Health Study

  Miho Iida1, Kunihiko Hayashi2, Yuki Ideno2, Kazue Nagai2, Yukiko Miyazaki3, Yasunori Sato1

  [Domestic presentation]  第34回　日本疫学会学術総会 (滋賀県大津市・びわ湖大津プリンスホテル) , 

  2024.01

  -

  2024.02

  , 

  日本疫学会

display all >>

Research Projects of Competitive Funds, etc. 【 Display / hide 】

Research Projects of Competitive Funds, etc. 【 Display / hide 】

• ステロイドホルモン・プロファイリングを用いた女性健康実現のための地域コホート研究

  2019.04

  -

  Present

  文部科学省, 科学研究費助成事業（科研費）, 若手研究, No Setting, Principal investigator

  　View Summary

  近年、エイジングに伴う健康寿命延伸・QOL向上において、ステロイドホルモンが果たす役割の重要性が明らかになってきた。とくに高齢女性においては、更年期状態の把握以外に女性ホルモン濃度を測定する意義は乏しいとされてきたのに対し、閉経後の卵巣や副腎における性ホルモンやその前駆体の分泌が明らかとなり、これらの網羅的なプロファイルと認知機能低下、フレイルや動脈硬化性疾患、骨粗鬆症等との関連について検証する意義は大きい。
  本研究では、高齢女性の健康状態やQOLに関連する代謝プロファイル・ステロイドホルモンプロファイルを明らかにし、女性の健康寿命・QOL向上に繋げることを目的とする。

• メタボロミクス疫学による個別か女性予防医療研究：更年期障害の客観的評価指標の探索と疾患発症予測の検討

  2018.10

  -

  2019.09

  大和証券ヘルス財団, 平成30年度（第45回）調査研究助成, 中高年・高齢者のための予防医学・臨床医学、並びに医療に関する調査研究, No Setting, Principal investigator

  　View Summary

  女性活躍社会の実現は，多様性を尊重する世界の潮流となっている。人口減少社会を迎えるわが国においても，2020年までに指導的地位に女性が占める割合を30％程度とする目標が掲げられている．一方で，社会において指導的地位を担う可能性が高い40-50代女性において，更年期障害を有する女性の労働能力の低下は，更年期障害なしの場合の8.4倍にも及ぶことが示されている．更年期障害は，軽症のものも含めると全女性の半数以上が経験するが，エストロゲン分泌低下の直接的影響を受ける血管運動神経系症状（例：ほてり，発汗）と，心理・社会的背景の変化に基づくエストロゲン低下を介さない精神神経系／運動神経系症状（例：抑うつ，めまい）の両者が複合的に絡み合い多彩な表現型を示すことから，さまざまな状態に応じて診断・治療の最適化を図る個別化予防医療の対象疾患として重要である.
  体内の代謝プロファイルを網羅的に評価することのできる手法であるメタボロミクスは，遺伝子-環境相互作用の結果を鋭敏に反映する手法として，疾患バイオマーカー探索から薬剤開発まで広く用いられつつある.そこで本研究では，地域在住の更年期女性を対象に，既存の各種ホルモン値に加え血中メタボロームを網羅的に測定し，更年期障害のメタボロームプロファイリングを通じて，更年期障害の客観的評価法を見出すことを目的とする．また，更年期障害を有する女性は将来心血管疾患を発症するリスクが高いことが報告されており，大規模疫学研究データを用いて，将来的な疾患発症予測に関する検証を第二の目的とする．
  更年期障害は社会的に広く認知されかつ治療法もおおむね確立しているにも関わらず，本邦における更年期女性の医療機関受診率やホルモン補充療法の普及率は低い．その背景には，ホルモン値測定による卵巣機能の評価は診断の参考になるが，症状の感じ方・現れ方に個人差が大きく主観的であり，実地臨床において客観的判断が難しいとの課題がある.本研究により更年期女性の健康課題に対して従来とは異なる新しい発想のアプローチを行うことで，更年期症状の客観的評価や将来の疾患発症に対する早期介入が可能となり，一人でも多くの女性のより良い生涯と日本の男女共同参画社会実現の一助となることが期待される．

• Integration of genomics and metabolomics for prevention of menopausal disorders

  2021.04

  -

  2023.03

  MEXT,JSPS, Grant-in-Aid for Scientific Research, Grant-in-Aid for Early-Career Scientists , Principal investigator

Awards 【 Display / hide 】

Awards 【 Display / hide 】

• The 90th Annual Meeting of Japanese Society for Hygiene, Young Investigator Award

  2022.03, Japanese Society for Hygiene, 閉経後女性の代謝プロファイルに対する出産経験の影響：鶴岡メタボロームコホート研究

  Type of Award： Award from Japanese society, conference, symposium, etc.

• 2017 JSOG Best Paper Award (Women's Health section)

  2017.04, Japan Society of Obstetrics and Gynecology (JSOG), 閉経後女性におけるメタボリック症候群の血漿メタボローム・プロファイリング

  Type of Award： Award from Japanese society, conference, symposium, etc.

• The 30th annual meeting of the Japan Society for Menopause and Women’s Health Best Presentation Award

  2015.11, Japan Society for Menopause and Women’s Health (JMWH), 閉経後女性におけるメタボリック症候群の血漿メタボローム解析：鶴岡メタボロームコホート研究

  Type of Award： Award from Japanese society, conference, symposium, etc.

• Kameda Medican Center, The Best Resident Award (22nd)

  2010.03

Courses Taught 【 Display / hide 】

Courses Taught 【 Display / hide 】

• PUBLIC HEALTH 2 (ADVANCED)

  2025

• EPIDEMIOLOGY AND PREVENTIVE MEDICINE

  2025

• ENVIRONMENTAL AND OCCUPATIONAL HEALTH

  2025

• BIOSTATISTICS AND MEDICAL INFORMATICS

  2025

• PUBLIC HEALTH 2 (ADVANCED)

  2024

display all >>

Courses Previously Taught 【 Display / hide 】

Courses Previously Taught 【 Display / hide 】

• 自主学習

  Keio University

  2018.04

  -

  2019.03

  , 

  Seminar, Lecturer outside of Keio, 3h, 5people

• 医学統計・医療情報

  Keio University

  2018.04

  -

  2019.03

  , 

  Seminar, Lecturer outside of Keio, 3h, 110people

• 医学統計・医療情報

  慶應義塾大学医学部

  2018.04

  -

  2019.03

• 公衆衛生学

  慶應義塾大学医学部

  2018.04

  -

  2019.03

Educational Activities and Special Notes 【 Display / hide 】

Educational Activities and Special Notes 【 Display / hide 】

• 自主学習

  2019.04

  -

  2019.11

  , Lecture at Education Method and Practice

• 公衆衛生学調査研究

  2018.10

  -

  2018.11

  , Special Affairs

• 医学統計・医療情報

  2018.09

  -

  2018.11

  , Special Affairs

• 自主学習

  2018.04

  -

  2018.11

  , Lecture at Education Method and Practice

Social Activities 【 Display / hide 】

Social Activities 【 Display / hide 】

• 生理に伴う不調への対処と学校における啓発の必要性

  NPO法人日本トイレ研究所, 中学・高校向け授業 「みんなで知ろう 生理に伴う不調とケア」 研修会, 

  , 

  2024.08

• 月経による健康課題と職場でできること

  NPO法人日本トイレ研究所, 第73回トイレラボ勉強会, 

  , 

  2024.04

• 働く女性の健康課題解決へー企業は何をするべきか

  佐賀県、女性の活躍推進佐賀県会議, 働く女性のこころとからだケアセミナー, 

  , 

  2024.01

• 男性も女性も知っておきたい女性の健康についてー妊娠・出産ー

  経済産業省, 教えよう！ココロ＆カラダ　厚生企画室勉強会, 

  , 

  2023.12

• 女性特有のからだの悩みとその対応について学ぼう

  日産自動車（株）横浜工場 安全健康管理課, 管理・監督者向けセミナー「女性の活躍と健康」, 

  , 

  2023.11

display all >>

Media Coverage 【 Display / hide 】

Media Coverage 【 Display / hide 】

• 女性のからだの悩みと職場の対策ーあなたと会社ができること

  東京都産業労働局, 東京都 働く女性のウエルネス向上委員会 事業セミナー, 2023.11

• 働く女性の月経トラブルー職場の支援の必要性ー

  日本経済新聞社, 丸の内キャリア塾スペシャルセミナー, 2023.03

Memberships in Academic Societies 【 Display / hide 】

Memberships in Academic Societies 【 Display / hide 】

• Japan Society of Obstetrics and Gynecology, 

  2010.04

  -

  Present

• Japan Society for Menopause and Women's Health, 

  2014

  -

  Present

• Japan Society of Gynecologic Oncology, 

  2010.04

  -

  2024.04

• Japan Epidemiological Association, 

  2017

  -

  Present

• Japan Society of Adolescentology, 

  2024

  -

  Present

display all >>

Committee Experiences 【 Display / hide 】

Committee Experiences 【 Display / hide 】

• 2021.04

  -

  Present

  世話人, 日本産業衛生学会 就労女性健康研究会

• 2020.11

  -

  Present

  代議員, 日本産業衛生学会

• 2018.09

  -

  Present

  食養委員, 慶應義塾大学病院食養委員会